Replies to post #92679 on Ayala Pharmaceuticals Inc (ADXS)

[zzaatt]

A 50 patient HOT Phase 1/2 will not cost very much.

In support of that, let's remember that HOT is the off the shelf, inexpensive technology (relative to NEO and other immune approaches that require samples from the patient and a complex, lengthy process to prepare the final patient ready product).

[mypekeispooped]

I was still surprised they haven't partnered it yet. I thought that may be the reason for the trial delay.